Skip to main content
Log in

Camurati–Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

  • Case Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

We report on a 46-year-old mother of Moroccan origin, suffering mainly from painful, swollen legs, and her 26-year-old son who had experienced intense pain in his legs, without fever, for approximately 3 years. They did not have dysmorphic features or abnormal gaits. Radiographic studies of the mother revealed diaphyseal sclerosis of the tibia and spondylosis of the thoracal and lumbar vertebrae. The son had sclerosis of the diaphyses of the metacarpalia of the left hand, the femur and the fibula. The other parts of the skeleton were normal. Several osteosclerotic/hyperostotic disorders, such as melorheostosis (present mostly in sporadic cases and affecting lower extremities) and van Buchem’s disease (autosomal recessive and commonly affecting the mandible) were considered as a diagnosis in the proposita. However, similar symptoms in the son of the proposita suggested an autosomal dominant inheritance pattern. This brought us to the diagnosis of progressive diaphyseal dysplasia (PDD) or Camurati–Engelmann disease (CED), an autosomal dominant disorder characterized by limb pain, reduced muscle mass, weakness, a waddling gait, progressive periosteal and endosteal sclerosis of the diaphyses of the long bones and sclerosis of the skull base. Mutations in the transforming growth factor (TGF)-β1 gene on chromosome 19q13.1 have been reported to cause this disorder. The diagnosis of PDD/CED in this family was confirmed at the molecular level by detection of a C-to-T transition at position 466, leading to an arginine-to-cysteine amino acid change (position 156) in exon 2 of the transforming growth factor-β1 (TGFB1) gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cockayne EA (1920) Case for diagnosis. Proc R Soc Med 13:132–136

    Google Scholar 

  2. Camurati M (1922) Di uno raro caso di osteite simmetrica ereditaria degli arti inferiori. Chir Organi Mov 6:662–665

    Google Scholar 

  3. Engelmann G (1929) Ein fall von osteopathia hyperostotica (sclerotisans) multiplex infantilis. Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr 39:1101–1106

    Google Scholar 

  4. Whyte MP (2003) Primer on the metabolic bone diseases and disorders of mineral metabolism, sect VIII. Genetic, developmental, and dysplastic skeletal disorders, fifth edn. Published by the American Society for Bone and Mineral Research, pp 449–478

  5. Vanhoenacker FM, De Beuckeleer LH, Van Hul W, Balemans W, Tan GJ, Hill SC, De Schepper AM (2000) Sclerosing bone dysplasias: genetic and radioclinical features. Eur Radiol 10:1423–1433

    Article  CAS  PubMed  Google Scholar 

  6. Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC, Taniguchi N, Niikawa N, Yoshiura K (2000) Domain-specific mutations in TGFB1 result in Camurati–Engelmann disease. Nat Genet 26:19–20

    Article  CAS  PubMed  Google Scholar 

  7. Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W (2000) Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati–Engelmann disease. Nat Genet 26:273–275

    Article  CAS  PubMed  Google Scholar 

  8. Campos-Xavier B, Saraiva JM, Savarirayan R, Verloes A, Feingold J, Faivre L, Munnich A, Le Merrer M, Cormier-Daire V (2001) Phenotypic variability at the TGF-beta1 locus in Camurati–Engelmann disease. Hum Genet 109:653–658

    Article  CAS  PubMed  Google Scholar 

  9. Mumm SR, Obrecht S, Podgornik MN, Whyte MP (2001) Camurati–Engelmann disease: new mutations in the latency-associated peptide of the transforming growth factor beta-1 gene. J Bone Miner Res 16:S223

    Google Scholar 

  10. Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W (2003) Transforming growth factor-beta1 mutations in Camurati–Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278:7718–7724

    Article  CAS  PubMed  Google Scholar 

  11. Hecht JT, Blanton SH, Broussard S, Scott A, Rhoades Hall C, Milunsky JM (2001) Evidence for locus heterogeneity in the Camurati–Engelmann (DPD1) syndrome. Clin Genet 59:198–200

    Google Scholar 

  12. Saito T, Kinoshita A, Yoshiura Ki, Makita Y, Wakui K, Honke K, Niikawa N, Taniguchi N (2001) Domain-specific mutations of a transforming growth factor (TGF)-beta1 latency-associated peptide cause Camurati–Engelmann disease because of the formation of a constitutively active form of TGF-beta1. J Biol Chem 276:11469–11472

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Simsek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simsek, S., Janssens, K., Kwee, M.L. et al. Camurati–Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family. Osteoporos Int 16, 1167–1170 (2005). https://doi.org/10.1007/s00198-005-1896-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-005-1896-2

Keywords

Navigation